Estrogen and Progesterone Receptors as Prognostic Factors in Breast Cancer

Abstract

The relation between estrogen receptors (ER) and/or progesterone receptors (PgR) and some clinical factors such as tumor size, axillary node involvement, histological tumor grade, and disease-free interval (DFI) in 500 patients with operable (TNM stage I-III) breast cancer was studied. ER-positive (ER⁺) tumors were commoner in older patients, whereas PgR-positive (PgR⁺) tumors were similarly distributed within the age groups. The concentration of ER⁺ protein also increased with age in contrast to PgR⁺ protein concentration. However, receptor status was not associated with menopausal status independently of age. Axillary node involvement influenced neither ER nor PgR status, but there was a statistically significant relation between tumor size and positivity of ER or PgR. There was no association between histologic tumor grade and either steroid receptor phenotype. DFI was longer in patients with ER⁺ than those with ER⁻ tumors, independently of axillary nodal status. The positivity of PgR in patients with ER⁺ tumors contributed to an even longer DFI, suggesting that the combination of ER/PgR is a better indicator of DFI than ER or PgR alone.